Sandra B. Horowitz
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 6
- CAR-T cell therapy research 5
-
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Bryan Do (3 shared papers)Sattva S. Neelapu (5 shared papers)Ranjit Nair (4 shared papers)Maria Alma Rodriguez (5 shared papers)Loretta J. Nastoupil (4 shared papers)Sairah Ahmed (5 shared papers)Jason R. Westin (5 shared papers)Paolo Strati (4 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (3 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)Blood Advances (1 paper)Cancer Treatment and Research Communications (1 paper)
- Partner nations
- United States
In The Last Decade
Sandra B. Horowitz
14 papers receiving 315 citations
Peers
Comparison fields: 5 of 46
- Oncology 226
- Hematology 73
- Immunology 60
- Dermatology 19
- Pathology and Forensic Medicine 37
Countries citing papers authored by Sandra B. Horowitz
This map shows the geographic impact of Sandra B. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra B. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra B. Horowitz more than expected).
Fields of papers citing papers by Sandra B. Horowitz
This network shows the impact of papers produced by Sandra B. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra B. Horowitz. The network helps show where Sandra B. Horowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra B. Horowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 132 | |
| 2 | 2017 | 52 | |
| 3 | 1999 | 27 | |
| 4 | 2020 | 22 | |
| 5 | 2014 | 18 | |
| 6 | 2020 | 17 | |
| 7 | 2019 | 14 | |
| 8 | 2020 | 11 | |
| 9 | 2015 | 9 | |
| 10 | 2014 | 7 | |
| 11 | 2022 | 7 | |
| 12 | 2020 | 4 | |
| 13 | 2012 | 2 | |
| 14 | 2020 | 1 | |
| 15 | 2015 | 0 |
About Sandra B. Horowitz
Sandra B. Horowitz is a scholar working on Oncology, Hematology, Molecular Biology, Pathology and Forensic Medicine and Immunology, having authored 15 papers that have together received 323 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (226 citations), Hematology (73 citations), Immunology (60 citations), Dermatology (19 citations) and Pathology and Forensic Medicine (37 citations). Sandra B. Horowitz has collaborated with scholars based in United States. Frequent co-authors include Bryan Do, Sattva S. Neelapu, Ranjit Nair, Maria Alma Rodriguez, Loretta J. Nastoupil, Sairah Ahmed, Jason R. Westin, Paolo Strati, Michael R. Green and Catherine M. Claussen. Their work appears in journals such as Blood, Journal of Clinical Oncology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Blood Advances and Cancer Treatment and Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.